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https://doi.org/10.1016/j.celrep.2020.108308SUMMARYIdentifying the molecular programs underlying human organ development and how they differ from model
species is key for understanding human health and disease. Developmental gene expression profiles provide
a window into the genes underlying organ development and a direct means to compare them across species.
We use a transcriptomic resource covering the development of seven organs to characterize the temporal
profiles of human genes associated with distinct disease classes and to determine, for each human gene,
the similarity of its spatiotemporal expression with its orthologs in rhesus macaque, mouse, rat, and rabbit.
We find clear associations between spatiotemporal profiles and the phenotypic manifestations of diseases.
We also find that half of human genes differ from their mouse orthologs in their temporal trajectories in at least
one of the organs. These include more than 200 genes associated with brain, heart, and liver disease for
which mouse models should undergo extra scrutiny.INTRODUCTION
The genetic programs underlying human organ development are
only partially understood, yet they are fundamental to under-
standing organ morphology, physiology, and disease (Bruneau,
2013; DeFalco and Capel, 2009; Si-Tayeb et al., 2010; Silbereis
et al., 2016; Vainio and Lin, 2002; Wang and Zoghbi, 2001). Gene
expression is a molecular readout of developmental processes
and therefore provides a window into the genes and regulatory
networks underlying organ development (Lein et al., 2017; Pan-
talacci and Semon, 2014). By densely profiling gene expression
throughout organ development, we get closer to identifying the
genes and molecular processes underlying organ differentiation,
maturation, and physiology (Bakken et al., 2016; Cardoso-Mor-
eira et al., 2019; Giudice et al., 2014; Houmard et al., 2009;
Zhu et al., 2018). In addition, spatiotemporal gene expression
profiles provide awealth of information on human disease genes,
which can be leveraged to gain new insights into the etiology and
symptomatology of diseases (Finucane et al., 2018; Gerrelli
et al., 2015; Lein et al., 2017; Li et al., 2018).
Much of the progressmade in identifying the genetic programs
underlying humanorgandevelopment has come from research in
model organisms.Mice andothermammals (e.g., rats and rhesus
macaques) are routinely used asmodels of normal human devel-
opment and disease because it is generally assumed that the ge-
netic programs underlying development are largely conserved
across these species.While usually true, there are also critical dif-
ferences between species during development, which underlieC
This is an open access article undthe large diversity of mammalian organ phenotypes (Bruneau,
2013; DeFalco and Capel, 2009; Lein et al., 2017; Si-tayeb
et al., 2016; Silbereis et al., 2016; Vainio and Lin, 2002; Wang
andZoghbi, 2001). Identifying the commonalities and differences
between the genetic programs underlying organ development in
different mammalian species is therefore key for assessing the
translatability of knowledge obtained from mammalian models
to understand human health and disease. Critically, gene expres-
sion profiles can be directly compared between species, espe-
cially when they are derived from matching cells/organs and
developmental stages. Although there are challenges (e.g., it is
easier to compare gene expression for more closely related spe-
cies, and comparisons are limited to genes with a 1:1 orthology
relationship between species), gene expression offers a direct
means to evaluate similarities and differences between species
in organ developmental programs (reviewed in Pantalacci and
Semon, 2014). While the relationship between gene expression
and phenotypes is not linear, identifying when and where gene
expression differs between humans and other species will help
identify the conditions (i.e., developmental stages, organs, and
genes) under which model species may not be well suited to
model human development and disease.
To characterize the organ developmental profiles of human
disease genes and gain new insights into the symptomatology
of diseases, we use a developmental gene expression resource
that we recently generated (Cardoso-Moreira et al., 2019). This
dataset densely covers the development of seven major organs
in humans and other mammals. For each human gene in ourell Reports 33, 108308, October 27, 2020 ª 2020 The Author(s). 1
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similarity of its spatiotemporal expression with that of its ortho-
logs in mouse, rat, rabbit, and rhesus macaque, providing a
new resource that is relevant for the choice of mammalian spe-
cies to model the action of individual genes and/or processes
in both healthy and pathological human organ development.
RESULTS
An Expression Atlas of Human Organ Development
This work is based on a resource that we recently generated
(Cardoso-Moreira et al., 2019), which provides human gene
expression time series for seven major organs: brain (forebrain/
cerebrum), cerebellum (hindbrain/cerebellum), heart, kidney,
liver, ovary, and testis (Figure 1A). The time series starts at
4 weeks post-conception (wpc), which corresponds to early
organogenesis for all organs except the heart (mid-organogen-
esis), and then covers prenatal development weekly until 20
wpc. The sampling restarts at birth and spans major develop-
mental milestones, including aging (Figure 1A; total of 297
RNA-sequencing [RNA-seq] libraries). This resource also pro-
vides matching datasets for four species commonly used to
study human development and disease: mouse (316 libraries),
rat (350 libraries), rabbit (315 libraries), and rhesus macaque
(starting at a late fetal stage that corresponds to 19 wpc in hu-
man; 154 libraries; STAR Methods).
We used a weighted gene co-expression network analysis to
identify the main clusters (modules) of highly correlated genes
during human organ development (STAR Methods). We then
characterized each module according to its developmental pro-
file (Figures 1B and S1A), functional and disease enrichments
(Figure 1B; Table S1), and proportion of transcription factors
(TFs) (Zhang et al., 2015), RNA-binding proteins (RBPs) (Gerst-
berger et al., 2014), and developmentally dynamic long noncod-
ing RNAs (lncRNAs) (Sarropoulos et al., 2019) (Figure 1B). As ex-
pected, we observed a match between the disease enrichments
of each module and its organ developmental profile (Figure 1B).
For example, module M3 comprises 2,420 genes predominantly
expressed in the liver and is enriched for several liver-related dis-
eases (e.g., fatty liver). Module M20 (822 genes) comprises
genes mainly expressed in the heart and is associated with a
number of cardiomyopathies.
Through ‘‘guilt by association’’, these modules additionally
provide putative functions for poorly characterized genes (Table
S2). Surprisingly, we identified a strong positive correlation be-
tween the fraction of protein-coding genes in a module that are
among the least studied in the human genome (based on
Stoeger et al., 2018) and the module’s fraction of dynamic
lncRNAs (r: +0.77, p value = 2 3 107; Figure S1B). Modules
rich in poorly studied protein-coding genes and developmentally
dynamic lncRNAs are frequently associated with high expres-
sion in the gonads (Figure 1B) but are also found in association
with high expression in each of the other organs (e.g., module
M9 for brain and module M11 for cerebellum).
Spatiotemporal Profiles of Disease Genes
We used this expression atlas of human organ development to
test for associations between the spatiotemporal profiles of hu-2 Cell Reports 33, 108308, October 27, 2020man disease genes and the etiology and phenotypic manifesta-
tion of human diseases.We first assigned genes to different clas-
ses of phenotypic severity by integrating a dataset of human
essential genes (Bartha et al., 2018) with a dataset of genes
associated with inherited disease in the manually curated Hu-
man Gene Mutation Database (‘‘disease genes’’) (Stenson
et al., 2017) (Figure 2A). We then compared the breadth of devel-
opmental expression for genes in these different classes (Fig-
ure 2B). This analysis revealed a clear association between
expression pleiotropy (i.e., fraction of total samples in which
genes are expressed) and the severity of phenotypes. Essential
genes that are not associated with disease are likely enriched for
embryonic lethality and are, congruently, the most pleiotropic.
The group of genes that when mutated range from lethality to
causing disease (often developmental disorders affecting multi-
ple organs) are less pleiotropic than embryonic lethals but are
more pleiotropic than genes only associated with disease (both
p values = 2 3 1016, Wilcoxon rank sum test, two sided; Fig-
ure 2B). Finally, nonlethal disease genes are more pleiotropic
than genes unassociated with any deleterious phenotypes (p
value = 2 3 105; Figure 2B). A similar association is obtained
when looking independently at organ and time specificity (Fig-
ure S2A). The breadth of developmental expression is therefore
positively correlated with phenotypic severity.
Human diseases differ in terms of severity, age of onset, and
organs affected, all of which should be reflected in the spatio-
temporal expression profiles of the underlying disease genes.
Therefore, we looked at the time and organ specificity of genes
associated with different classes of disease (Stenson et al.,
2017) (Figure 2C). As expected, the specificity of the spatiotem-
poral profiles of disease genes differs considerably among dis-
ease classes. Genes implicated in developmental disorders,
cancer, and diseases of the nervous system tend to be
ubiquitously expressed, whereas genes causing heart and
reproductive diseases tend to have more restricted expression
(Figure 2C).
Further insights were obtained by analyzing the temporal tra-
jectories of disease genes within the organs they affect. To do
this, we used a soft clustering approach to identify the most
common expression profiles in each organ and assigned each
gene a probability of belonging to each of the clusters (STAR
Methods; Table S2). Disease genes are enriched within specific
clusters, which are disease and organ specific. For example,
genes associated with heart disease are significantly enriched
among genes characterized by a progressive increase in expres-
sion throughout heart development (Figure S2B; Bonferroni-cor-
rected p value = 2 3 106, binomial test), whereas genes asso-
ciated with metabolic diseases are enriched among genes that
exhibit a strong upregulation in the liver in the first months after
birth (Figure S2C; Bonferroni-corrected p value = 3 3 1015,
binomial test). Within the brain, we focused on the temporal tra-
jectories of genes associated with three neurodevelopmental
disorders: primary microcephaly, autism spectrum disorders,
and schizophrenia (STARMethods). Consistent with these disor-
ders having different etiologies and ages of onset, the associated
genes are significantly enriched among distinct temporal profiles
in the brain (Figure 2D). Genes causing primary microcephaly
show their highest expression at the earliest developmental
A
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Figure 1. An Expression Atlas of Human Organ Development
(A) Description of the dataset. The dots mark the developmental stages sampled in each organ (median of two replicates), and its colors reflect the colors used
throughout the figures to represent each organ.
(B)Modules in the gene co-expression network (number of genes in eachmodule in parentheses). The left panel shows the correlations between eachmodule and
the expression levels in each organ or developmental time (full developmental profiles in Figure S1A). The color intensity and the size of the circles are proportional
to the correlation coefficients. A positive correlation with developmental time (first column) means higher expression late in development, and a negative cor-
relation means higher expression early in development. The middle panel shows the fraction of genes in each module that correspond to TFs, RBPs, devel-
opmentally dynamic lncRNAs, and poorly studied protein-coding genes (i.e., genes with three or fewer publications). The right panel shows examples of
overrepresented diseases (FDR <1%, hypergeometric test). Table S1 lists the top five biological and disease enrichments (FDR <1%) for each of the 32 modules.
The modules are ordered vertically by decreasing number of genes. Module 0 (bottom) includes genes not assigned to any of the other modules.
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Figure 2. Spatiotemporal Profiles of Disease Genes
(A) Number of expressed (RPKM >1) protein-coding genes in different classes of phenotypic severity.
(B) Expression pleiotropy of genes in different classes of phenotypic severity (p values fromWilcoxon rank sum test, two sided; the number of genes in each class
is shown in A).
(C) Organ and time specificity (median across organs) of genes associated with different disease classes (number of genes in each class in parentheses). Genes
are only assigned to one class; those affecting multiple organs appear in the classes ‘‘Multiple organs,’’ ‘‘Developmental’’, or ‘‘Other organs’’ depending on
whether they affect multiple organs that include at least one of the organs in this study, are associated with developmental phenotypes, or affect organs that are
not part of this study, respectively.
(D) Genes associated with primary microcephaly, autism, and schizophrenia are significantly enriched in distinct expression clusters in the brain (binomial tests
with Bonferroni correction). On the left are the developmental profiles for the clusters identified through soft clustering of the brain developmental samples. The y
axis shows standardized expression levels (STAR Methods). The profile of each gene in the cluster is shown in red; the white line shows the cluster center. The
genes associated with each disorder are significantly enriched in only one of the eight clusters (right).
(legend continued on next page)
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OPEN ACCESSstages followed by a progressive decrease in expression (Fig-
ure 2D; 9 out of 15 genes, Bonferroni-corrected p value =
0.002, binomial test), whereas genes implicated in schizophrenia
show the opposite profile: a progressive increase in expression
throughout development (16 out of 45 genes, Bonferroni-cor-
rected p value = 0.0005). Genes associated with autism are ex-
pressed throughout prenatal development and subsequently
display a sharp decrease in expression near birth (Figure 2D;
27 out of 79 genes, Bonferroni-corrected p value = 0.008,
consistent with Satterstrom et al., 2020). The two temporal pro-
files enriched with microcephaly- and autism-associated genes
are also enriched with essential genes (Bonferroni-corrected
p value < 1015, binomial test).
Organ-Specific Phenotypes of Ubiquitously Expressed
Genes
Most disease genes that we analyzed are associated with phe-
notypes in multiple organs (3,060 genes [71%]), but this still
leaves hundreds of genes that affect exclusively one organ.
Many of these genes with organ-specific phenotypes present a
puzzle in biomedical research, because their expression is not
organ specific (Barshir et al., 2018; Lage et al., 2008). Our anal-
ysis of developmental transcriptomes further highlights this
issue. Genes associated with organ-specific phenotypes exhibit
dynamic temporal profiles in a similar number of organs as genes
associated with phenotypes across multiple organs (i.e., median
of four organs for both gene sets; Figure S2D). This raises the
intriguing question of how mutations that predominantly disrupt
the coding sequences of genes employed during the develop-
ment of multiple organs result in diseases that are organ specific.
While a number of factors may explain this phenomenon,
including alternative splicing (Omer Javed et al., 2018), functional
redundancy (Barshir et al., 2018), and dependency on the char-
acteristics of specific cell types like protein-misfolding diseases
in long-lived neurons, it has been suggested that pathologies
tend to be associated with the organ where the genes display
elevated expression (Lage et al., 2008). This prompted us to
ask if genes associated with organ-specific diseases exhibit their
maximum expression during the development of the affected or-
gan.We focused on heart, neurodevelopmental, psychiatric, and
metabolic diseases (the latter tested in association with the liver)
and found a strong association between the organ of maximum
expression during development and the organ where the pathol-
ogy manifests (Figure 2E). We found that 56% of the genes
exclusively associated with heart disease showmaximal expres-
sion in the heart (versus 15% for all genes, Bonferroni-corrected
p value = 93 1015, binomial test; Figure 2E), 56% of the genes
with an exclusively metabolic phenotype show maximal expres-
sion in the liver (versus 19% for all genes, Bonferroni-corrected p
value = 93 1015; Figure 2E), and 39% of the genes exclusively
associated with neurodevelopmental diseases show maximal
expression in the brain (versus 32% for all genes, Bonferroni-
corrected p value = 0.1; Figure 2E).(E) Organs where genes associated with organ-specific phenotypes show
correction.
(F) Time specificity in the different organs of genes with heart- and metabolic-sp
In (B), (C), and (F), the boxplots depict the median ±25th and 75th percentiles, wAt least for heart disease, the duration of gene expression may
also help explain organ-specific pathologies. Genes expressed
in multiple organs that have heart-specific phenotypes are ubiq-
uitously expressed during heart development but show a signif-
icantly higher time specificity (i.e., shorter expression window) in
the other organs (all Bonferroni-corrected p values < 104, Wil-
coxon rank sum test, two sided; Figure 2F). In contrast, the dura-
tion of gene expression does not appear to underlie metabolic-
or neurodevelopmental-specific phenotypes, as we see no
difference in the time specificity of genes in the affected organs
versus the others (Figures 2F and S2E). Overall, the association
of pathology with the level of gene expression and, to a lesser
extent, the duration of gene expression suggests that the devel-
opment of organ-specific pathologies can at least in some cases
be explained by differences in the abundance of the cell types
that express the mutated gene in the different organs.
Most Disease Genes Have Orthologs in Mammalian
Models
The extensive use of mice, rats, and other mammals in biomed-
ical research is predicated on the assumption of an overall con-
servation of developmental programs between humans and
these species. This assumption has been largely supported by
comparative analyses of developmental expression profiles
(Cardoso-Moreira et al., 2019) and comparative analyses of the
human and mouse trans-acting regulatory circuitry (Stergachis
et al., 2014). However, there are exceptions to this overall con-
servation that can profoundly impact the translatability of pheno-
types between humans and other species.
One exception applies to genes that have duplicated recently
in human history and therefore do not have a strict 1:1 orthology
relationship with other species. The lack of 1:1 orthologs poses
challenges to the study of recently evolved human genes, which
is reflected in younger genes (i.e., more recently originated) be-
ing more poorly studied than older genes (as measured by the
number of publications; Figure S3; see also Zhang et al.,
2012). In this context, it is notable that the younger genes are,
the less likely they are to be associated with disease (with the
caveat that they are also more poorly studied) (Figure 3A). While
29% of human genes with 1:1 orthologs across vertebrates are
associated with disease, the same is true for only 1% of hu-
man-specific genes (Figure 3A). One likely explanation is that
the younger genes are, the more organ- and time-specific they
are also likely to be (Figure 3B; see also Milinkovitch et al.,
2009). This relation is important because (as shown above) the
more specifically genes are expressed during development
(temporally and spatially), the less severe are the phenotypes
associated with mutations in those genes (Figure 2B).
Of the 4,295 disease-associated genes that are expressed in
the human developmental atlas, only 155 (4%) do not have a
1:1 ortholog in at least one of four mammals commonly used
to study human physiology: mouse, rat, rabbit, and rhesus ma-
caque. Of these 155 genes, most (85%) originated beforemaximum expression. p values are from binomial tests after Bonferroni
ecific phenotypes.
ith the whiskers at 1.5 times the interquartile range.
Cell Reports 33, 108308, October 27, 2020 5
Vertebrates
(11942)
Tetrapods
(2137)
Amniotes
(604)
Mammals
(1039)
Therians
(921)
Eutherians
(714)
Boreoeutheria
(107)
Euarchontoglires
(61)
Primates
(116)
Catarrhini
(90)
Hominoidea
(32)
Hominidae
(56)
Hominin
(113)
Human
(95)
0.00 0.25 0.50 0.75 1.00
Organ−specificity
0.25 0.50 0.75 1.00
Time−specificity
Vertebrates
(11942)
Tetrapods
(2137)
Amniotes
(604)
Mammals
(1039)
Therians
(921)
Eutherians
(714)
Boreoeutheria
(107)
Euarchontoglires
(61)
Primates
(116)
Catarrhini
(90)
Hominoidea
(32)
Hominidae
(56)
Hominin
(113)
Human
(95)
3.02.01.00.0
Proportion of disease−associated genes
G
en
es
' e
vo
lu
tio
na
ry
 a
ge
A B
Figure 3. Recently Originated Genes Are Infrequently Associated with Disease
(A) The proportion of disease-associated genes decreases for groups of genes of successively younger evolutionary ages. 2,231 genes do not have an age
assignment, and of these, 310 (13%) are associated with human disease.
(B) Organ and time specificity of human genes with different evolutionary ages.
In (A) and (B), the youngest genes are those that are human specific (top), and the oldest are those shared across vertebrates (bottom). In parentheses are the
number of genes in each age class.
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OPEN ACCESSprimates split from the glires lineage (i.e., rodents and rabbits),
which indicates gene loss events in the non-human lineages or
genome annotation problems (Shao et al., 2019). Overall, these
analyses suggest that most human disease genes could in prin-
ciple be studied in one of the four mammalian models.
Presence/Absence Expression Differences Are Rare
between Species
We next evaluated the extent of differences between human and
each of the four model species in terms of stark differences in
spatiotemporal profiles of 1:1 orthologs: presence/absence of
gene expression in a given organ or large differences in expres-
sion pleiotropy across multiple organs. Our analyses showed
that differences between human and the other species in terms
of presence/absence of gene expression in an organ are rare. In
a comparison between human and mouse, only 1%–3% of pro-
tein-coding genes (177–372 genes depending on the organ) are
robustly expressed (reads per kilobase of exon per million map-
ped reads [RPKM]R 5) in human, but not in mouse (RPKM% 1).
These percentages are similar for the comparisonswith the other
species (i.e., 1%–2% of genes robustly expressed in human are
not expressed in rat, rabbit, or rhesus macaque). Although rare,
these differences include disease genes. For example, among
genes robustly expressed in heart in human, but not in mouse,
are 17 genes associated with heart disease (similar to the ex-
pected number given presence/absence differences in the
heart). These include NKX2-6, which causes conotruncal heart
malformations in human (Ta-Shma et al., 2014) that, congruently,
are not recapitulated by a mouse knockout (Bello et al., 2015).
The developmental profile of NKX2-6 in the human heart is
ancestral; heart expression was lost specifically in rodents,
and this is therefore an example of a disease gene that would
be better studied in the rabbit (Figure 4A). Genes associated
with neurological diseases are depleted among the set of genes
expressed in the human, but not in the mouse, brain (11 differ6 Cell Reports 33, 108308, October 27, 2020versus 28 expected, p value = 4 3 104, binomial test). Among
the exceptions isCHRNA2, a gene expressed in the human brain
starting at birth that has been implicated in epilepsy (Aridon et al.,
2006; Conti et al., 2015). Once again, and congruently, this clin-
ical phenotype is not recapitulated in the mouse knockout (Bello
et al., 2015) (Figure 4B).
The breadth of spatiotemporal expression is also very similar
between human genes and their orthologs in mouse, rat, rabbit,
and rhesus macaque. They are highly correlated in terms of their
organ specificity (Pearson’s r = 0.86, all Bonferroni-corrected p
values < 1015), time specificity (r = 0.67–0.84 for individual or-
gans and 0.83–0.84 for median time specificity, all Bonferroni-
corrected p values < 1015), and, therefore, global expression
pleiotropy (r = 0.85–0.88, all Bonferroni-corrected p values <
1015). There are only 141 genes expressed in at least half the
human samples but in fewer than 10% of the mouse samples,
and 172 genes with the opposite pattern (Figure S4). These
genes are depleted for essential genes (4% versus 11% in entire
dataset, p value = 8 3 106, binomial test) and disease genes
(16% versus 26% in entire dataset, p value = 0.02, binomial
test). Similar results are obtained in comparisons between hu-
man and each of the other species (Figure S4). Together with
the results above, these analyses indicate that differences in
the breadth and presence/absence of gene expression between
humans and other species are confined to a small set of genes.
However, when present, they can translate into relevant pheno-
typic differences that are relevant to biomedical research.
Organ Developmental Trajectory Differences Are
Common
Although stark differences in gene expression are rare between
humans and other species, we previously showed that it is not
uncommon for genes with broad spatiotemporal profiles to
evolve new organ-specific developmental trajectories (Car-
doso-Moreira et al., 2019). In that work, we studied the evolution
A B
Figure 4. Suitability of the Mouse as a Model
(A) Developmental profile of NKX2-6 in human, mouse, rat, rabbit, and opossum (marsupial). NKX2-6 is robustly expressed in the human heart, but not in mouse,
and the conotruncal heart malformations observed in human are not recapitulated by a mouse knockout. The human heart profile of NKX2-6 is ancestral, as it is
similar to the profiles in rabbit and opossum.
(B) Developmental profile of CHRNA2 in human and mouse. CHRNA2 is robustly expressed in the human brain, but not in mouse, and the epileptic phenotypes
observed in human are not recapitulated by a mouse knockout.
In (A) and (B), the x axis shows samples for each organ ordered from early to late development (stages sampled in Table S4), and the y axis shows expression
levels in reads per kilobase of exon model per million mapped reads (RPKM).
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mammals using a phylogenetic approach that assigned changes
in organ temporal trajectories to individual phylogenetic
branches (Cardoso-Moreira et al., 2019). This limited the number
of human genes that could be tested for trajectory changes
(1,871–3,980 genes depending on the organ), because jointly
analyzing distantly related species considerably reduced the
number of available 1:1 orthologs, and trajectory changes had
to be unambiguously assigned to one branch of the phylogenetic
tree.
Here, we aimed to identify differences in organ developmental
trajectories between human and each of the four mammalian
models for the maximum number of human genes. Therefore,
we compared the developmental profiles of human genes with
their orthologs in each of the species separately, in a pairwise
manner. Doing pairwise comparisons allowed us to double or tri-
ple (depending on the organ) the number of human genes that
could be evaluated for organ trajectory differences (e.g.,
5,253–8,666 genes in human-mouse comparisons). We used a
two-step approach. First, we used soft clustering to identify
themain types (or clusters) of temporal trajectories in each organ
jointly for human and non-human orthologs (STAR Methods).
Second, we identified all instances where the human gene and
its ortholog were assigned to different clusters (5% false discov-
ery rate [FDR]; STARMethods; Figures 5 and S5). We were inter-
ested in genes that differ between species in the entirety of their
temporal trajectory (e.g., genes assigned to cluster 0 in one spe-
cies and to cluster 1 in another in Figure 5 for the brain) and in
genes that differ in only part of the time series (e.g., genes as-signed to cluster 2 in one species and to cluster 6 in the other
in Figure 5 for the brain).
Overall, we identified thousands of genes with different
developmental trajectories between human and each of the
other species (Figure 6A; Table S3). Because we performed
our trajectory comparisons in a pairwise fashion, we could
examine our calls across trios of species (e.g., mouse, rat,
and human) to evaluate the sensitivity and specificity of our
approach. Genes inferred to have a similar trajectory between
mouse and rat and between mouse and human should also
have a similar trajectory between human and rat. This was
true for ~96% of the calls, consistent with our 5% FDR
threshold (Figure S6A). Conversely, genes inferred to be similar
between mouse and rat and different between mouse and hu-
man should have a different trajectory between human and rat.
This was true for 65%–82% of the calls, suggesting our
approach is conservative when calling for species differences
(Figure S6A). We further evaluated the consistency of our tra-
jectory calls using an external dataset generated by the Psy-
chENCODE consortium that compared gene expression pro-
files between human and rhesus macaque for 11 different
areas of the neocortex for the prenatal, postnatal and adult pe-
riods (Li et al., 2018; Zhu et al., 2018). In support of our
approach, the genes that we identified as having different brain
developmental trajectories between human and rhesus ma-
caque were also significantly more likely to show spatial and
temporal differences between these two species in the Psy-
chENCODE dataset (Figure S6B; p value = 1 3 105, Wilcoxon
rank sum test).Cell Reports 33, 108308, October 27, 2020 7
Figure 5. Developmental Trajectory Differences between Human and Mouse in Brain, Heart, and Kidney
We used soft clustering to group human genes and their mouse orthologs according to their temporal expression in each organ. The genes for which the human
and mouse orthologs were assigned to a different cluster are shown on top. Each line represents a pair of human-mouse orthologs with a significant trajectory
difference and shows the cluster assignment in human (top) and mouse (bottom). The lines are colored according to the human cluster assignment. The clusters
identified in each organ are shown below (gray lines correspond to individual genes and the colored lines to the cluster center). The y axis shows the log
normalized expression levels, and the x axis shows the samples ordered from early to late development. The same analysis for cerebellum, kidney, and testis is
shown in Figure S5.
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man and rhesus macaque (diverged ~29 million years ago)
than between human and mouse, rat, or rabbit (diverged ~90
million years ago) (Figure 6A). However, for all organs and
despite the same divergence time, a higher proportion of genes
differ between human and mouse than between human and
rabbit (Figure 6A). In human-mouse comparisons, 51% of the
genes tested show a different developmental trajectory in at
least one of the organs (6,816 out of 13,471 genes tested). In
human-rat comparisons, this percentage is 45% (5,459 out of
12,155 genes), and in human-rabbit comparisons, it is only
38% (4,568 out of 11,731 genes). These species differences
are robust to using the same gene set of 1:1 orthologs for all
pairwise species comparisons (Figure S6C) and using different
clustering parameters (Figure S6D). The observation that there
are more genes with trajectory differences between human and
mouse than between human and rabbit is consistent with the
rodent lineage having evolved a larger number of trajectory dif-
ferences (Cardoso-Moreira et al., 2019) and suggests that rab-8 Cell Reports 33, 108308, October 27, 2020bits have some advantages over mice for studying human
biology.
Next, we set to characterize the genes with trajectory differ-
ences between humans and the other species. Below, we report
on the human-mouse comparison, but the results are consistent
across all species comparisons. An analysis of the GTEx dataset
(Lonsdale et al., 2013), which contains human gene expression
profiles for hundreds of adults across multiple tissues, shows
that genes with trajectory differences between species do not
show greater variation in gene expression among humans (Fig-
ure S6E; STAR Methods). Therefore, the species differences
are not a consequence of the genes involved having more vari-
able expression profiles. At the level of the coding sequence,
we found that genes with trajectory differences are under similar
levels of functional constraint as genes with similar trajectories.
For most organs, genes in both groups show similar levels of
intolerance to loss-of-function mutations (Figure S7A). The
exception are the neural tissues (brain and cerebellum), where
genes with trajectory differences show more tolerance to
A
B
C
Figure 6. Developmental Trajectory Differences
(A) Percentage of genes in each organ that have different tra-
jectories between human and mouse, rat, rabbit, and rhesus
macaque (because of the shorter time series, this analysis was
only performed for brain, heart, and liver in rhesus). The sets of
genes compared differ between species as they correspond to
the total number of 1:1 orthologs available between human and
each species. Figure S6C shows the same analysis but using
the same set of 1:1 orthologs across all species (similar results).
Table S3 lists the genes tested for trajectory differences and
those found to be significantly different between human and
each of the other species.
(B) Examples of human disease genes with different develop-
mental trajectories between human and mouse in the affected
organ (FDR <5%).
(C) Percentage of genes in brain, heart, and liver that differ in
trajectories between human and mouse. Bonferroni-corrected
p values for comparisons between disease and non-disease
genes are from Fisher’s exact tests, and Bonferroni-corrected
p values for comparisons of disease genes with different ages
of onset are from binomial tests.
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OPEN ACCESSfunctional mutations than those with similar trajectories (Fig-
ure S7A). Similar relationships apply to genes’ intolerance to
copy-number variation (duplications and deletions); genes with
trajectory differences in the neural tissues are slightly more
tolerant to copy-number variation than genes with similar trajec-
tories, and no differences are observed for the other organs (Fig-
ure S7B). Interestingly, genes with different trajectories in the
brain (but not other organs) are also enriched among a set of
genes identified as carrying signs of positive selection in their
coding sequences across mammals (Kosiol et al., 2008) (Benja-
mini-Hochberg corrected p value = 0.02, Fisher’s exact test).
Finally, across organs, genes with trajectory differences are en-
riched for protein metabolism (Benjamini-Hochberg corrected p
value = 0.0001, hypergeometric test).
Organ Trajectory Differences among Disease Genes
The genes depicted in Figure 6B are associated with diseases
that affect the organ in which human andmouse display different
trajectories. For these genes, the disease etiology may not be
fully recapitulated by mouse models. The mouse knockouts
are still expected to affect the development of the organ associ-
ated with the disease, but the cellular and developmental
context of the phenotypes in mouse could differ substantially
from those in human. It is therefore noteworthy that genes asso-
ciated with human disease are less likely than non-disease
genes to differ in their trajectories between human and mouse
(Figure 6C). Genes causing diseases that affect the brain and
liver are depleted for trajectory differences between human
and mouse in each of the organs (Figure 6C; p value = 0.002
for the brain, p value = 0.1 for the heart, and p value = 9 3
105 for the liver, Fisher’s exact test after Bonferroni correction).
This is also true for comparisons between human and other spe-
cies (Figure S7C). Nevertheless, that still leaves more than 200
disease genes whose developmental profiles may not be fully
recapitulated in the mouse (Figure 6C; ~40% fewer genes in
the rabbit; Figure S7C).
We further asked if genes underlying diseases with different
ages of onset are equally likely to differ in their organ trajectories
between human and mouse. Although the number of disease
genes associated with an exclusive congenital or exclusive post-
natal onset is low, we found that genes with congenital onsets
rarely differ in terms of their developmental trajectories between
human andmouse (i.e., only 1 out of 82 genes causing disease in
the brain, heart, or liver; Figure 6C), whereas genes with post-
natal onsets are more likely to show differences (Figure 6C;
same applies to comparisons between human and other spe-
cies; Figure S7C). This suggests that diseases with a congenital
onset may be easier to study in model species than diseases
whose phenotypic manifestations start later in life.
DISCUSSION
In order to shed new light on the causes and phenotypic mani-
festations of human diseases, we integrated a resource of hu-
man organ developmental gene expression profiles with data-
sets of human essential and disease genes. We found that the
breadth of developmental expression is positively correlated
with phenotypic severity and that it varies considerably among10 Cell Reports 33, 108308, October 27, 2020disease classes. Disease-associated genes are enriched within
specific developmental modules in the organs affected. For
example, genes associated with different brain developmental
disorders show distinct temporal profiles during brain develop-
ment. Overall, we found a clear association between spatiotem-
poral profiles and the phenotypic manifestations of diseases.
The analysis of developmental transcriptomes further
strengthened the apparent paradox of ubiquitously expressed
genes often having organ-specific phenotypes (Barshir et al.,
2018; Hekselman and Yeger-Lotem, 2020; Lage et al., 2008).
We could not distinguish genes associated with organ-specific
phenotypes from those associated with multi-organ phenotypes
based on the breadth of spatiotemporal profiles, which were
similar. However, for genes associated with organ-specific phe-
notypes, we found a strong association between the organ
affected and the organ of maximal expression during develop-
ment. This association suggests that some organ-specific pa-
thologies could be explained by differences between organs in
the spatial and temporal abundance of the cells expressing the
mutated gene.
Gene expression links geneswith their organismal phenotypes
and hence offers a direct means to compare both across spe-
cies. This is not without its challenges. Gene expression differ-
ences can relate to phenotypes in complex ways, genes that
have duplicated cannot be directly compared across species,
and cross-species comparisons of whole organs cannot directly
address the extent to which differences in cell abundances
underly changes in gene expression (discussed below) (Panta-
lacci and Semon, 2014). Despite these challenges, comparing
gene expression between species for matching organs and
developmental stages provides a powerful tool to evaluate the
likelihood that insights obtained from studies in model species
can be directly transferable to human. Within this context, it is
notable that most (96%) genes associated with human disease
have 1:1 orthologs in commonly usedmammalianmodel species
and can, therefore, be directly compared.
Overall, we found that stark changes in gene expression (e.g.,
presence/absence of expression) are rare between species.
However, instances of such changes sometimes occur in dis-
ease genes, and in these cases, the differences that we identify
may explain why animal models fail to recapitulate human phe-
notypes. In contrast, we found that differences in temporal tra-
jectories during organ development are common between hu-
mans and other species. Approximately half of human genes
exhibit a different developmental trajectory from their mouse or-
thologs in at least one of the organs. In further support of the use
of model organisms for disease research, we found that disease
genes are less likely to differ than the other genes. Nevertheless,
we still identified more than 200 genes known to be causally
associated with brain, heart, and/or liver disease that differ in
their developmental trajectories between human and mouse in
the affected organ. It is unclear how the subtler differences in
developmental trajectories that we have identified (e.g.,
COL4A2 in Figure 6B) translate at the level of phenotypes. Sill,
we suggest that for disease genes with different temporal trajec-
tories between human andmouse, the existing mousemodels of
human diseases should undergo extra scrutiny, and the possibil-
ity of studying alternativemodels should be carefully considered.
Article
ll
OPEN ACCESSWhen human disease genes with organ trajectory differences
are studied in animal models, their genetic manipulation (e.g.,
knockout) is still expected to affect the functioning of the organ
affected by the human disease. Genes with trajectory differ-
ences show dynamic temporal profiles in both species, suggest-
ing the orthologs play roles during organ development in the two
species, but potentially different ones. This poses considerable
challenges for phenotyping efforts of animal models of human
disease, with abnormal organ function expected in the model
species when genes have both similar and different develop-
mental trajectories. Luckily, efforts to systematically and
comprehensively phenotype animal models of human disease
are currently underway that will address these challenges (Ca-
cheiro et al., 2019; Meehan et al., 2017).
How differences in organ developmental trajectories translate
into phenotypic differences between species will depend to a
large extent on the reasons for the trajectory differences. Trajec-
tory differences can be created by gene expression differences
between species in homologous cell types, differences between
species in cellular composition, and/or differences between spe-
cies in the cell types that express orthologous genes. All of these
non-mutually exclusive possibilities can decrease the likelihood
that the phenotype associated with a human gene will be fully
recapitulated in a model species. However, the magnitude of
the phenotypic differences is expected to differ depending on
the underlying reasons. For example, trajectory differences
created by changes in the identity of the cell types that express
an orthologous gene could lead to the greatest phenotypic diver-
gence. Such differences would be highly relevant to interpreting
animal models of human disease genes with adult onsets,
because they would suggest a distinct cellular basis for the dis-
ease in humans and in the model species. Endeavors that seek
to clarify the causes of trajectory differences therefore represent
a key next step, and the application of single-cell technologies
across species will greatly aid these efforts (Bakken et al.,
2020; Shami et al., 2020; Xue et al., 2013).
Gene expression is only one of several steps connecting
genes to their phenotypes (Buccitelli and Selbach, 2020). Simi-
larities and differences in gene expression between species
will not always translate into conserved and divergent pheno-
types, respectively. This notwithstanding, detailed comparisons
of developmental gene expression profiles, as performed here,
can substantially help to assess the translatability of the knowl-
edge gathered for individual genes from model species to
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OPEN ACCESSSTAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Deposited Data
human developmental time-series for the brain,
cerebellum, heart, kidney, liver, ovary and testis
Cardoso-Moreira et al., 2019 ArrayExpress: E-MTAB-6814
rhesus macaque developmental time-series for the
brain, cerebellum, heart, kidney, liver, ovary and testis
Cardoso-Moreira et al., 2019 ArrayExpress: E-MTAB-6813
mouse developmental time-series for the brain,
cerebellum, heart, kidney, liver, ovary and testis
Cardoso-Moreira et al., 2019 ArrayExpress: E-MTAB-6798
rat developmental time-series for the brain,
cerebellum, heart, kidney, liver, ovary and testis
Cardoso-Moreira et al., 2019 ArrayExpress: E-MTAB-6811
rabbit developmental time-series for the brain,
cerebellum, heart, kidney, liver, ovary and testis
Cardoso-Moreira et al., 2019 ArrayExpress: E-MTAB-6782
Software and Algorithms
WGCNA (1.61) Langfelder and Horvath, 2008 https://horvath.genetics.ucla.edu/html/
CoexpressionNetwork/Rpackages/WGCNA/
DESeq2 (1.12.4) Love et al., 2014 https://bioconductor.org/packages/release/
bioc/html/DESeq2.html
WebGestalt (0.0.5) Wang et al., 2017 https://cran.r-project.org/web/packages/
WebGestaltR/index.html
mFuzz (2.32.0) Futschik and Carlisle, 2005;
Kumar and Futschik, 2007
https://www.bioconductor.org/packages/
release/bioc/html/Mfuzz.html
GPClust Hensman et al., 2012, 2013, 2015 https://github.com/SheffieldML/GPclust
R (3.3.2) R Core Team, 2014 https://www.r-project.org/
ggplot2 (2.2.1) Wickham, 2009 https://cran.r-project.org/web/packages/
ggplot2/index.html
gridExtra (2.2.1) Auguie, 2016 https://cran.r-project.org/web/packages/
gridExtra/index.html
reshape2 (1.4.2) Wickham, 2007 https://cran.r-project.org/web/packages/
reshape2/index.html
plyr (1.8.4) Wickham, 2011 https://cran.r-project.org/web/packages/
plyr/index.html
factoextra (1.0.4) Kassambara and Mundt, 2017 https://cran.r-project.org/web/packages/
factoextra/index.html
tidyverse (1.2.1) Wickham, 2017 https://cran.r-project.org/web/packages/
tidyverse/index.htmlRESOURCE AVAILABILITY
Lead contact
Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Margarida Cardoso-
Moreira (margarida.cardosomoreira@crick.ac.uk).
Materials availability
This study did not generate new unique reagents.
Data and code availability
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Resource
From a mammalian resource on organ development (Cardoso-Moreira et al., 2019), we analyzed data from 1,443 strand-specific
RNA-seq libraries sequenced to a median depth of 33 million reads: 297 from human, 316 from mouse (outbred strain CD-1 -
RjOrl:SWISS), 350 from rat (outbred strain Holtzman SD), 315 from rabbit (outbred New Zealand breed) and 165 from rhesus ma-
caque. The organs, developmental stages and replicates sampled in each species are described in Table S4. The mouse time
series started at e10.5 and there were prenatal samples available for each day until birth (i.e., e18.5). There were postnatal sam-
ples for 5 stages: P0, P3, P14, P28 and P63. The rat time series started at e11 and there were prenatal samples available for each
day until birth (i.e., e20). There were postnatal samples for 6 stages: P0, P3, P7, P14, P42 and P112. The rabbit time series started
at e12 and there were 11 prenatal stages available up to and until e27 (gestation lasts ~29-32 days). There were postnatal samples
for 4 stages: P0, P14, P84 and P186-P548. Finally, the time series for rhesus macaque started at a late fetal stage (e93) and there
were 5 prenatal stages available up to and until e130 (gestation last ~167 days). There were postnatal samples for 8 stages: P0,
P23, 5-6 months of age, 1 year, 3 years, 9 years, 14-15 years, and 20-26 years. For mouse, rat, and rabbit, there were typically 4
replicates (2 males and 2 females) per stage, except for ovary and testis (2 replicates). For human and rhesus macaque, the me-
dian number of replicates was 2.
Gene co-expression networks
We built gene co-expression networks using weighted correlation network analysis (WGCNA 1.61) (Langfelder and Horvath, 2008).
We used as input data the read counts after applying the variance stabilizing (VS) transformation implemented in DESeq2 (1.12.4)
(Love et al., 2014). Each stage was represented by the median across replicates. In addition to protein-coding genes, we included
a set of 5,887 lncRNAs that show significant differential temporal expression in at least one organ and that show multiple signatures
for being enriched with functional genes (Sarropoulos et al., 2019). We only excluded genes that failed to reach an RPKM (reads per
kilobase of exon model per million mapped reads) across all stages and organs higher than 1. Using WGCNA we built a signed
network (based on the correlation across all stages and organs) using a power of 10 and default parameters. We then correlated
the eigengenes for each module with the sample traits (i.e., organ and developmental stage).
We characterized eachmodule in terms of biological processes and disease enrichments (GLAD4U) using the R implementation of
WebGestalt (FDR% 0.01; version 0.0.5) (Wang et al., 2017). The lists of TFs are from the animalTFDB (version 2.0) (Zhang et al., 2015)
and the list of RNA-binding proteins are from the work of Gerstberger and colleagues (Gerstberger et al., 2014).
Inherited disease genes
The list of genes associated with human inherited disease was obtained from themanually curated HGMD (PRO 17.1) (Stenson et al.,
2017). We only used genes with disease-causing mutations (DM tag; Table S2). Genes associated with DMmutations were mapped
onto the Unified Medical Language System (UMLS), and aggregated into one or more of the following high level disease types: Eye,
Nervous system, Reproductive, Cancer, Skin, Heart, Blood, Blood Coagulation, Endocrine, Immune, Digestive, Genitourinary, Meta-
bolic, Ear Nose & Throat, Respiratory, Developmental, Musculoskeletal, and Psychiatric (Stenson et al., 2017).
We also characterized the developmental profiles of genes associated with three neurodevelopmental disorders: primary micro-
cephaly, autism spectrum disorders and schizophrenia. For all three disorders we limited our analyses to those genes with dynamic
temporal expression in the brain and asked if they were enriched in particular clusters when compared to all genes showing dynamic
temporal expression in the brain (binomial tests with Bonferroni correction). This translated into 15 genes associated with primary
microcephaly and with dynamic temporal profiles in the brain (out of a set of 16 genes associated with this condition; Verloes
et al., 1993), 79 genes associated with autism spectrum disorders (out of 102; Satterstrom et al., 2020) and 45 genes associated
with schizophrenia (out of 75; Ripke et al., 2014). For our analysis of genes associated with schizophrenia we only considered loci
where atmost two geneswere associatedwith the causative variant.We also performed the analysis of genes associated with autism
spectrum disorders using a larger dataset of autism associated genes (164 with dynamic temporal profiles out of 233; Iossifov et al.,
2015) and obtained the same result (i.e., significant enrichment in cluster 8, 62 out of 164 genes, Bonferroni-corrected P-value = 83
109). The list of human essential genes was obtained from the work of Bartha and colleagues (Bartha et al., 2018).
The time- and organ-specificity indexes were based on the Tau metric of tissue-specificity (Yanai et al., 2005) and were retrieved
from the developmental resource (Cardoso-Moreira et al., 2019). Both indexes range from 0 (broad expression) to 1 (restricted
expression). The pleiotropy index is the number of samples where a gene is expressed (RPKM > 1) over the total number of samples.
Themost common temporal profiles in each organwere identified using the soft-clustering approach (c-means) implemented in the
R package mFuzz (2.32.0) (Futschik and Carlisle, 2005; Kumar and Futschik, 2007). The clustering was restricted to genes previously
identified as showing significant temporal differential expression in each organ (i.e., developmentally dynamic genes) (Cardoso-Mor-
eira et al., 2019). We used as input the VS-transformed counts. Prior to clustering, mFuzz standardizes the expression values of every
gene so that the average expression value for each gene is zero and the standard deviation of its expression profile is one. This is
done to make genes comparable. The number of clusters was set to 6-8 depending on the organ.Cell Reports 33, 108308, October 27, 2020 e2
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The classification of human genes according to their evolutionary age (i.e., to when they first originated) was retrived from the Gen-
Tree database (http://gentree.ioz.ac.cn/) (Shao et al., 2019). The age assignments are based on the human genome assembly hg19
and on Ensembl version 73 annotations.
The lists of orthologs between human genes and mouse, rat, rabbit, and rhesus macaque was obtained using Ensembl’s BioMart
(Yates et al., 2016). The lists of orthologs are based on Ensembl version 85 annotations.
Organ developmental trajectories
For each organ, we compared the developmental trajectories of orthologous genes previously identified as showing significant tem-
poral differential expression (Cardoso-Moreira et al., 2019). We used as input the VS-transformed counts (median across replicates)
for matching stages between human and each of the other species. The developmental stage correspondences across species were
retrieved from the developmental resource (Cardoso-Moreira et al., 2019). We used GPClust (Hensman et al., 2012, 2013, 2015),
which clusters time-series using Gaussian processes, to cluster the combined data for human and each of the other species. We
set the noise variance (k2.variance.fix) to 0.7 and let GPClust infer the number of clusters. For each gene, GPClust assigned the prob-
ability of it belonging to each of the clusters. Therefore, for each gene we obtained a vector of probabilities that could be directly
compared between pairs of 1:1 orthologs. We calculated the probability that pairs of orthologs were in the same cluster and used
an FDR cut off of 5% to identify the genes that differed in trajectory between human and each of the other species. In Table S3,
we provide the P-values for each organ and species (adjusted for multiple testing using the Benjamini-Hochberg procedure (Benja-
mini and Hochberg, 1995)) for the null hypothesis that orthologs have the same trajectory, and their classification as ‘same’ or
‘different’ based on an FDR of 5%.
Changing the noise variance (k2.variance.fix) impacts the number of clusters that are identified. The fewer the clusters, the more
distinct are the expression profiles among the clusters, and vice versa. The degree of distinctiveness among the clusters impacts the
type of trajectory differences that are identified between species. If the k2.variance.fix is increased to 1, the number of clusters iden-
tified decreases and only genes with opposing developmental trajectories (i.e., whose expression is negatively correlated throughout
the time series) are identified as having trajectory differences between species (Figure S7D). Decreasing the k2.variance.fix to 0.5 has
the opposite effect; a larger number of clusters are identified and a larger number of genes with subtler temporal differences is iden-
tified (Figure S7D). In this study we were interested both in genes with opposing developmental trajectories (e.g., RIT1 and ABCA1 in
Figure 6B) and in genes that differ in only part of the time series (e.g., CLP1 and ABCB4 in Figure 6B). A k2.variance.fix of 1 identified
the former but a k2.variance.fix of 0.7 was required to identify the latter (all genes identified using a k2.variance.fix of 1 are also iden-
tified using the 0.7 cutoff). Further decreasing the k2.variance.fix increases the number of clusters but the extra clusters identified are
not enriched with specific biological processes and are strongly biased toward having genes from only one of the species (data not
shown). For these reasons, we decided to use a k2.variance.fix of 0.7 in our work. However, in Table S5 we provide the results from
this analysis (Benjamini-Hochberg adjusted P-values) using the three cutoffs (1, 0.7 and 0.5). Irrespective of the k2.variance.fix
threshold used, we always observe more differences between human and mouse (and rat) than between human and rabbit (Fig-
ure S6D), and the correlation coefficient distributions for genes identified as having different trajectories are at least as low as those
of genes that have no orthology relationship with each other (Figure S7D).
Characterization trajectory differences
The PsychENCODE consortium provides calls of differential gene expression between human and rhesus macaque for 16 brain
regions (11 areas of the cerebral neocortex, hippocampus, amygdala, striatum,mediodorsal nucleus of thalamus, and cerebellar cor-
tex) for 3 developmental periods (prenatal, postnatal, and adult) (Zhu et al., 2018). We compared the genes that we identified as hav-
ing similar or different brain developmental trajectories between human and rhesus macaque in terms of the number of comparisons
(regions * developmental periods) that the PsychENCODE dataset called as differentially expressed between the two species.We did
this analysis using 1) the set of 11 cerebral neocortex samples (Figure S6B), and 2) all brain regions except for the cerebellum (i.e., 15
regions). The result was the same.
We calculated variation in gene expression across the GTEx dataset (Lonsdale et al., 2013) using three measures: 1) the standard
deviation (SD), 2) the coefficient of variation (CV, standard deviation divided by the mean), and 3) the residual CV. The SD and CV are
the classical measures to estimate variation in gene expression but have known biases: SD tends to be biased toward genes with
high expression levels, whereas the CV tends to be biased toward genes with low expression levels (Simonovsky et al., 2019).
Because expression variation is highly correlated with the levels of gene expression (Anders and Huber, 2010), we also used a mea-
sure of expression variation that takes into account gene expression levels, the residual CV (Sigalova et al., 2020). The residual CV
uses the residuals from a locally weighed regression (LOESS) of the CV on median expression, and it is highly correlated with other
measures of expression variation that take into account expression levels (Sigalova et al., 2020). Using all threemeasures, we consis-
tently found that in the brain and testis, genes with trajectory differences tend to show less variation in gene expression than genes
with similar trajectories, whereas no differences are observed in the other organs. It is unclear why there is a difference for the brain
and testis. The values for CV and residual CV shown in Figure S6E are from Sigalova and colleagues (Sigalova et al., 2020) based on
GTEx samples for the cortex (matched to our brain samples), cerebellum, left ventricle (matched to our heart samples, similar results
using the atrial appendage samples), liver and testis.e3 Cell Reports 33, 108308, October 27, 2020
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variation intolerance score (RVIS), and 2) the probability of being intolerant to loss-of-function mutations (pLI score). Both metrics
were applied to data from the Exome Aggregation Consortium (ExAC) (Lek et al., 2016). We obtained the pLI and RVIS scores
from the work of Dickinson and colleagues (Dickinson et al., 2016). The RVIS and pLI scores give similar results. We used the
copy-number variation (CNV) intolerance score as applied to the ExAC data from the work of Ruderfer and colleagues (Ruderfer
et al., 2016).
The animal and organ silhouettes used in the figures were originally published by Cardoso-Moreira and colleagues (Cardoso-Mor-
eira et al., 2019).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses and plots were done in R (3.3.2) (R Core Team, 2014). Plots were created using the R packages ggplot2 (2.2.1)
(Wickham, 2009), gridExtra (2.2.1) (Auguie, 2016), reshape2 (1.4.2) (Wickham, 2007), plyr (1.8.4) (Wickham, 2011), factoextra (1.0.4)
(Kassambara and Mundt, 2017), and tidyverse (1.2.1) (Wickham, 2017).
The statistical details of our analyses are reported in the figure legends, figures, Results and STAR Methods. These include the
statistical tests used, the exact numbers of genes tested and the multiple-test corrections performed.Cell Reports 33, 108308, October 27, 2020 e4
